During the gestation period, expectations are raised about the formation and growth of the baby. Uncertainties arise about the sex and health, especially when there are factors that increase the risk of the foetus being a carrier of a chromosomal abnormality.
In the past, detection of foetal abnormalities was carried out through invasive testing by taking genetic material from the placenta (chorionic villus sampling) or amniotic fluid (amniocentesis).
Today, non-invasive prenatal testing can be performed, avoiding the risks of invasive procedures, with rapid results and a reliability close to 99%. In the event that any pathology is detected, diagnostic confirmation with amniocentesis is recommended.
This test analyses the free foetal DNA circulating in maternal blood and determines the probability of chromosomal alterations in the baby.
Our non-invasive tests offer the patient a high level of security for the detection of different alterations such as:
Trisomy 21 or Down syndrome
Trisomy 18 or Edwards’ syndrome
Trisomy 13 or Patau’s syndrome
Turner’s syndrome (X0), Klinefelter’s syndrome (XXY), XYYY and triple X syndrome
Three to seven microdeletion syndromes
The percentage of foetal DNA obtained and the sex of the baby are also reported.
In our clinics we have various kits available depending on the patient’s interest:
BBsafe Standard- click here for more information
BBsafe Plus – click here for more information
BBsafe Advanced- click here for more information
For any further information about the Non-Invasive Prenatal Test, please contact us:
Central phone Analiza: 902 676 457 or 914 297 541
Email [email protected]
